Published in Am J Cardiol on February 03, 2006
Angiotensin II induces afterdepolarizations via reactive oxygen species and calmodulin kinase II signaling. J Mol Cell Cardiol (2010) 1.05
PKC activation and PIP(2) depletion underlie biphasic regulation of IKs by Gq-coupled receptors. J Mol Cell Cardiol (2009) 1.04
The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. Heart Rhythm (2008) 1.03
Cardiac oxidative stress and dysfunction by fine concentrated ambient particles (CAPs) are mediated by angiotensin-II. Inhal Toxicol (2010) 0.89
Targeting cardiac mast cells: pharmacological modulation of the local renin-angiotensin system. Curr Pharm Des (2011) 0.89
Angiotensin receptor type 1 single nucleotide polymorphism 1166A/C is associated with malignant arrhythmias and altered circulating miR-155 levels in patients with chronic heart failure. J Card Fail (2012) 0.87
E-NTPDase1/CD39 modulates renin release from heart mast cells during ischemia/reperfusion: a novel cardioprotective role. FASEB J (2014) 0.83
Modulation of the QT interval duration in hypertension with antihypertensive treatment. Hypertens Res (2015) 0.81
Single therapeutic and supratherapeutic doses of sacubitril/valsartan (LCZ696) do not affect cardiac repolarization. Eur J Clin Pharmacol (2016) 0.75
Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol (2009) 5.70
Atherosclerosis across 4000 years of human history: the Horus study of four ancient populations. Lancet (2013) 5.61
Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med (2003) 5.43
The MOGE(S) classification for a phenotype-genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J Am Coll Cardiol (2013) 4.81
Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol (2005) 4.29
A mouse model of mitochondrial disease reveals germline selection against severe mtDNA mutations. Science (2008) 3.95
Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications. J Am Soc Echocardiogr (2010) 3.80
Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol (2010) 3.45
In vivo diagnosis of plaque erosion and calcified nodule in patients with acute coronary syndrome by intravascular optical coherence tomography. J Am Coll Cardiol (2013) 3.43
Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol (2010) 3.21
Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol (2007) 2.97
Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol (2009) 2.93
We are all for elevating VR…. JACC Cardiovasc Imaging (2011) 2.62
Extension of borderzone myocardium in postinfarction dilated cardiomyopathy. J Am Coll Cardiol (2002) 2.52
The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation (2007) 2.50
OCT-based diagnosis and management of STEMI associated with intact fibrous cap. JACC Cardiovasc Imaging (2013) 2.31
Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res (2003) 2.08
Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol (2010) 2.07
Functional consequences of caspase activation in cardiac myocytes. Proc Natl Acad Sci U S A (2002) 1.98
Molecular imaging of interstitial alterations in remodeling myocardium after myocardial infarction. J Am Coll Cardiol (2008) 1.97
Left ventricular structure and function: basic science for cardiac imaging. J Am Coll Cardiol (2006) 1.92
Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. JACC Cardiovasc Imaging (2012) 1.85
Revisiting the pathogenesis of rheumatic fever and carditis. Nat Rev Cardiol (2013) 1.84
Functional characterization of atrial electrograms in sinus rhythm delineates sites of parasympathetic innervation in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol (2007) 1.83
Characterization and quantification of vortex flow in the human left ventricle by contrast echocardiography using vector particle image velocimetry. JACC Cardiovasc Imaging (2008) 1.79
Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol (2007) 1.78
Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS. JACC Cardiovasc Imaging (2012) 1.77
Past, present, and future of annexin A5: from protein discovery to clinical applications. J Nucl Med (2005) 1.75
Cardiologist concordance with the American College of Cardiology appropriate use criteria for cardiac testing in patients with coronary artery disease. Am J Cardiol (2012) 1.70
Why all the focus on cardiac imaging? JACC Cardiovasc Imaging (2010) 1.68
Noninvasive imaging of angiotensin receptors after myocardial infarction. JACC Cardiovasc Imaging (2008) 1.67
Left ventricular form and function revisited: applied translational science to cardiovascular ultrasound imaging. J Am Soc Echocardiogr (2007) 1.65
American Society of Echocardiography: Remote Echocardiography with Web-Based Assessments for Referrals at a Distance (ASE-REWARD) Study. J Am Soc Echocardiogr (2013) 1.62
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. JACC Cardiovasc Imaging (2009) 1.61
Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis. J Nucl Cardiol (2009) 1.60
Myeloperoxidase, subclinical atherosclerosis, and cardiovascular disease events. JACC Cardiovasc Imaging (2009) 1.58
Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: a technique with potential for noninvasive imaging of vulnerable plaque. Circulation (2003) 1.55
Coronary CT angiographic characteristics of culprit lesions in acute coronary syndromes not related to plaque rupture as defined by optical coherence tomography and angioscopy. Eur Heart J (2011) 1.53
Second-hand tobacco smoke in never smokers is a significant risk factor for coronary artery calcification. JACC Cardiovasc Imaging (2013) 1.52
Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imaging. J Nucl Cardiol (2012) 1.51
Multimodality Intravascular Imaging to Evaluate Sex Differences in Plaque Morphology in Stable CAD. JACC Cardiovasc Imaging (2016) 1.51
Should old acquaintance be forgot: Auld Lang Syne Q waves! JACC Cardiovasc Imaging (2013) 1.49
Computed tomographic angiography-verified plaque characteristics and slow-flow phenomenon during percutaneous coronary intervention. JACC Cardiovasc Interv (2012) 1.49
Direct imaging of exercise-induced myocardial ischemia with fluorine-18-labeled deoxyglucose and Tc-99m-sestamibi in coronary artery disease. Circulation (2003) 1.46
Molecular imaging of human ACE-1 expression in transgenic rats. JACC Cardiovasc Imaging (2012) 1.45
Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol (2013) 1.44
Combined NIRS and IVUS imaging detects vulnerable plaque using a single catheter system: a head-to-head comparison with OCT. EuroIntervention (2014) 1.44
Optimizing CAD diagnosis in China with CT angiography. J Cardiovasc Comput Tomogr (2009) 1.43
Risk factors for heart failure. Med Clin North Am (2004) 1.43
Digital Mammography and Screening for Coronary Artery Disease. JACC Cardiovasc Imaging (2016) 1.41
Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol (2011) 1.39
Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med (2004) 1.34
One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging (2009) 1.34
Mitral stenosis. Lancet (2009) 1.32
Assessment of nonischemic myocardial fibrosis. J Am Coll Cardiol (2010) 1.32
Emerging trends in CV flow visualization. JACC Cardiovasc Imaging (2012) 1.30
In vitro measurement of cell death with the annexin A5 affinity assay. Nat Protoc (2006) 1.30
Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. J Am Coll Cardiol (2008) 1.29
Radionuclide imaging for the detection of inflammation in vulnerable plaques. J Am Coll Cardiol (2006) 1.25
Novel combined miniature optical coherence tomography ultrasound probe for in vivo intravascular imaging. J Biomed Opt (2011) 1.25
Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol (2007) 1.24
Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis. JACC Cardiovasc Imaging (2010) 1.24
Pharmacological suppression of hepcidin increases macrophage cholesterol efflux and reduces foam cell formation and atherosclerosis. Arterioscler Thromb Vasc Biol (2011) 1.23
Noncompaction of the left ventricle: primary cardiomyopathy with an elusive genetic etiology. Curr Opin Pediatr (2007) 1.22
Apoptosis and heart failure: clinical relevance and therapeutic target. J Mol Cell Cardiol (2004) 1.22
An ovine model of postinfarction dilated cardiomyopathy. Ann Thorac Surg (2002) 1.18
Cell surface-expressed phosphatidylserine and annexin A5 open a novel portal of cell entry. J Biol Chem (2004) 1.17
Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization. Biochim Biophys Acta (2008) 1.17
Annexin A5 uptake in ischemic myocardium: demonstration of reversible phosphatidylserine externalization and feasibility of radionuclide imaging. J Nucl Med (2010) 1.16
Atherosclerotic plaque characterization by 0.5-mm-slice multislice computed tomographic imaging. Circ J (2007) 1.15
MDCT of the S-shaped sinoatrial node artery. AJR Am J Roentgenol (2008) 1.13
Serial coronary CT angiography-verified changes in plaque characteristics as an end point: evaluation of effect of statin intervention. JACC Cardiovasc Imaging (2010) 1.12
Impact of an automated multimodality point-of-order decision support tool on rates of appropriate testing and clinical decision making for individuals with suspected coronary artery disease: a prospective multicenter study. J Am Coll Cardiol (2013) 1.11
Cardiac magnetic resonance imaging: infarct size is an independent predictor of mortality in patients with coronary artery disease. Magn Reson Imaging (2010) 1.09
Intracoronary optical diagnostics current status, limitations, and potential. JACC Cardiovasc Interv (2011) 1.09
Clinical implications of apoptosis in ischemic myocardium. Curr Probl Cardiol (2006) 1.09
Noninvasive detection of programmed cell loss with 99mTc-labeled annexin A5 in heart failure. J Nucl Med (2007) 1.08
Counting heads in the war against cancer: defining the role of annexin A5 imaging in cancer treatment and surveillance. Cancer Res (2006) 1.08
Use of an oxygen-carrying blood substitute to improve intravascular optical coherence tomography imaging. J Biomed Opt (2009) 1.07
From adequate evidence to optimal evidence. JACC Cardiovasc Imaging (2012) 1.06
Histopathologic evaluation of basilar artery atherosclerosis. J Neurol Sci (2011) 1.05
Arterial supply to sinuatrial and atrioventricular nodes: imaging with multidetector CT. Radiology (2007) 1.05
Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor. J Nucl Med (2009) 1.04
Noninvasive imaging of atherosclerotic lesions in apolipoprotein E-deficient and low-density-lipoprotein receptor-deficient mice with annexin A5. J Nucl Med (2006) 1.04
Role of left ventricular twist mechanics in the assessment of cardiac dyssynchrony in heart failure. JACC Cardiovasc Imaging (2009) 1.04
Intravascular atherosclerotic imaging with combined fluorescence and optical coherence tomography probe based on a double-clad fiber combiner. J Biomed Opt (2012) 1.03
Imaging vulnerable plaque by ultrasound. J Am Coll Cardiol (2006) 1.03
The extent of coronary atherosclerosis is associated with increasing circulating levels of high sensitive cardiac troponin T. Arterioscler Thromb Vasc Biol (2010) 1.02
Broad and specific caspase inhibitor-induced acute repression of apoptosis in atherosclerotic lesions evaluated by radiolabeled annexin A5 imaging. J Am Coll Cardiol (2007) 1.02
Contrast echocardiography for assessing left ventricular vortex strength in heart failure: a prospective cohort study. Eur Heart J Cardiovasc Imaging (2013) 1.01
Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv (2013) 1.00
Comprehensive overview of definitions for optical coherence tomography-based plaque and stent analyses. Coron Artery Dis (2014) 0.99
Bachmann Bundle and its arterial supply: imaging with multidetector CT--implications for interatrial conduction abnormalities and arrhythmias. Radiology (2008) 0.99
The popcorn plaques. Nat Med (2007) 0.99
Sex differences in mortality associated with computed tomographic angiographic measurements of obstructive and nonobstructive coronary artery disease: an exploratory analysis. Circ Cardiovasc Imaging (2010) 0.99
Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches. Exp Cell Res (2005) 0.98
Vitamin K-antagonists accelerate atherosclerotic calcification and induce a vulnerable plaque phenotype. PLoS One (2012) 0.97